NCT07595016 Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia
| NCT ID | NCT07595016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Withings |
| Condition | Hypertension |
| Study Type | INTERVENTIONAL |
| Enrollment | 45 participants |
| Start Date | 2026-05-11 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 45 participants in total. It began in 2026-05-11 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in pregnancy and pre-eclampsia
Eligibility Criteria
Inclusion Criteria: * Patient older than 18 years; * Known pregnancy, in second or third trimester of pregnancy ( \> 3 months); * Patient normotensive, hypertensive or in preeclampsia; * Patient who signed the informed consent form; * Patient followed-up at site (in-patient or out-patient); * Patient with arm circumference between 22 cm and 42 cm. Exclusion Criteria: * Patient unable to give a consent or understand properly protocol information; * Patient suffering from arrhythmia; * Patient with poor quality of Korotkov sounds; * Patient for whom K5 sounds are absent; * Patient wearing an implantable electric medical device (pacemaker,…); * Patient with both upper arms suffering from open wound and/or damaged skin.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07595016 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07595016 currently recruiting?
Yes, NCT07595016 is actively recruiting participants. Contact the research team at clinical-trials@withings.com for enrollment information.
Where is the NCT07595016 trial being conducted?
This trial is being conducted at Yerevan, Armenia.
Who is sponsoring the NCT07595016 clinical trial?
NCT07595016 is sponsored by Withings. The trial plans to enroll 45 participants.